Abstract: The present invention is directed to a nucleic acid encoding a lepidopteran glutamate-gated chloride channel. Vectors and host cells comprising the nucleic acid are also provided. A method of identifying agents that modulate the activity of a lepidopteran glutamate-gated chloride channel is also provided. Such agents are useful as insecticides.
Type:
Grant
Filed:
August 20, 2003
Date of Patent:
June 19, 2007
Assignee:
Bayer CropScience AG
Inventors:
Xiao-Zhuo Michelle Wang, Xavier Georges Sarda, Michael David Tomalski, Vincent Paul Mary Wingate
Abstract: The present invention relates to biomarkers and the use of biomarkers for the prediction and prognosis of cancer as well as the use of biomarkers to monitor the efficacy of cancer treatment. Specifically, this invention relates to the use of stanniocalcin as a biomarker for VEGFR2 inhibitors.
Type:
Application
Filed:
December 10, 2004
Publication date:
June 14, 2007
Applicant:
BAYER PHARMACEUTICALS CORPORATION
Inventors:
James Kasper, Nicole Pauloski, Ian Taylor, James Elting, Timothy Sarr
Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
Type:
Grant
Filed:
August 18, 2003
Date of Patent:
June 12, 2007
Assignee:
Bayer Healthcare AG
Inventors:
Heike Gielen-Haertwig, Volkhart Min-Jian Li, Ulrich Rosentreter, Karl-Heinz Schlemmer, Swen Allerheiligen, Leila Telan, Lars Bärfacker, Jörg Keldenich, Mary F. Fitzgerald, Kevin Nash, Barbara Albrecht, Dirk Meurer
Abstract: The present invention relates to novel pyrazolyl-substituted heterocycles of the formula (I) in which X, Y, Z and Het are as defined in the disclosure, to processes for their preparation, and to their use as pesticides, microbicides and herbicides.
Type:
Grant
Filed:
October 21, 2002
Date of Patent:
June 12, 2007
Assignee:
Bayer CropScience, AG
Inventors:
Reiner Fischer, Astrid Ullmann, Thomas Bretschneider, Axel Trautwein, Ralf Wischnat, Angelika Lubos-Erdelen, legal representative, Dieter Feucht, Mark Wilhelm Drewes, Christoph Erdelen, deceased
Abstract: The invention provides a human 5-HT7 which is associated with the cardiovascular disorders, dermatological disorders, gastrointestinal and liver diseases, cancer disorders, inflammatory diseases, metabolic diseases, hematological disorders, respiratory diseases, neurological disorders and urological disorders. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular disorders, dermatological disorders, gastrointestinal and liver diseases, cancer disorders, inflammatory diseases, metabolic diseases, hematological disorders, respiratory diseases, neurological disorders and urological disorders. The invention also features compounds which bind to and/or activate or inhibit the activity of 5-HT7 as well as pharmaceutical compositions comprising such compounds.
Type:
Application
Filed:
May 15, 2004
Publication date:
June 7, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Stefan Golz, Ulf Bruggemeier, Andreas Geerts
Abstract: The present invention relates to a pyrimidine derivative of the formula (I) and salts thereof which is useful as an active ingredient of pharmaceutical preparations. The pyrimidine derivative of the present invention has excellent CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and can be used for the prophylaxis and treatment of diseases associated with CRTH2 activity, in particular for the treatment of allergic diseases, such as asthma, allergic rhinitis, atopic dermatitis, and allergic conjunctivitis; eosinophil-related diseases, such as Churg-Strauss syndrome and sinusitis; basophil-related diseases, such as basophilic leukemia, chronic urticaria and basophilic leukocytosis in human and other mammals; and inflammatory diseases characterized by T lymphocytes and profuse leukocyte infiltrates such as psoriasis, eczema, inflammatory bowel disease, ulcerative colitis, Crohn's disease, COPD (chronic obstructive pulmonary disorder) and arthritis.
Type:
Application
Filed:
April 14, 2004
Publication date:
June 7, 2007
Applicants:
ACTIMIS PHARMACEUTICALS, INC., BAYER AG, BAYER HEALTH CARE AG
Abstract: The invention relates to antibacterial amide macrocycles, to methods for the production thereof, and to the use of the same for producing pharmaceuticals for the treatment and/or prophylaxis of illness, especially bacterial infections.
Type:
Application
Filed:
June 10, 2003
Publication date:
June 7, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Thomas Lampe, Isabelle Adelt, Dieter Beyer, Nina Brunner, Rainer Endermann, Kerstin Ehlert, Heinz-Peter Kroll, Franz Nussbaum, Siegfried Raddatz, Joachim Rudolph, Guido Schiffer, Andreas Schumacher, Yolanda Canco-Grande, Martin Michels, Stefan Weigand
Abstract: The invention relates to novel 2-halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives of the formula (I) in which A, B, G, X, Y and Z are as defined above, to a plurality of processes and intermediates for their preparation and to their use as pesticides and/or herbicides, and also to selective herbicidal compositions comprising firstly the 2-halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives of the formula (I) and secondly at least one crop plant compatibility-improving compound.
Type:
Application
Filed:
November 4, 2004
Publication date:
June 7, 2007
Applicant:
BAYER CROPSCIENCE AKTIENGESELLSCHAFT
Inventors:
Reiner Fischer, Stefan Lehr, Mark Drewes, Dieter Feucht, Peter Losel, Olga Malsam, Guido Bojack, Christian Arnold, Thomas Auler, Martin Hills, Heinz Kehne, Christopher Rosinger
Abstract: A process for monitoring and/or controlling a nitrating process, having the following steps: measuring inline infrared spectra of nitric acid content in a reaction mixture stream downstream of the nitration reaction, preferably near-infrared spectra, evaluating the measured spectra by means of a computer-assisted, matrix-specific calibration model for the purpose of determining the content of nitric acid, transmitting the results of spectrometric examination to a process control system, inputting the results of spectrometric examination for the purpose of specifying the content of nitric acid in the acid phase into a regulator (224) for control of the metering (207,217) of nitric acid into a nitrating reactor.
Type:
Grant
Filed:
February 2, 2004
Date of Patent:
June 5, 2007
Assignee:
Bayer MaterialScience AG
Inventors:
Claus Riehle, Marcus Brand, Frank Hilgers, Klaus Jäger, Rainer Giesen, Heinz-Josef Hamacher, Udo Wolf
Abstract: The present invention provides a method of preparing 1-acetyl-1-chlorocyclopropane from 1,3 dichloro-2-pentanone by reaction with base in the presence of a phase transfer catalyst. The reaction may be run in the presence or absence of an organic solvent and in a continuous or batch process.
Abstract: The invention relates to novel phenyl-substituted cyclopentane- and cyclohexane-1,3-dione derivatives of the formula (I) in which W, X, Y, Z, A, B, Q1, Q2, Q3, Q4, G and m are as defined in the disclosure, to processes and intermediates for their preparation and to their use as pesticides, microbicides and/or herbicides.
Type:
Grant
Filed:
October 9, 2003
Date of Patent:
June 5, 2007
Assignee:
Bayer CropScience Ag
Inventors:
Reiner Fischer, Stefan Hillebrand, Axel Trautwein, Astrid Ullmann, Mark Wilhelm Drewes, Dieter Feucht, Jörg Konze, Karl-Heinz Kuck, Ulrike Wachendorff-Neumann
Abstract: The invention relates to aqueous suspension concentrates which comprise: (1) one or more active substances from the group consisting of the oxadiazoles, (2) one or more surfactants based on non-salt-like substituted phenol ethers, (3) one or more thickeners based on aluminum silicate, and (4) optionally additional formulation auxiliaries, and also (5) optionally additional surfactants other than component (2). This makes possible, in addition to avoiding crystal growth, inter alia also highly concentrated aqueous herbicidal compositions with good distribution of active substance.
Type:
Application
Filed:
November 22, 2006
Publication date:
May 31, 2007
Applicant:
Bayer CropScience GmbH
Inventors:
Gerhard Frisch, Roland Deckwer, Janine Rude, Ulrike Ebersold
Abstract: The invention relates to aqueous suspension concentrates comprising (1) one or more active ingredients from the group of the 2,4-diamino-s-triazines, which are N-substituted on one amino group by a (hetero)aryl(hetero)alkyl group, (2) one or more surfactants based on nonsaltlike substituted phenol ethers, (3) one or more aluminum silicate-based thickeners, and (4) if desired, additional formulation assistants, and also (5) if desired, additional surfactants different from component (2). Besides the highly concentrated formulation of active ingredients this also allows the biological effect to be improved for the same application rate.
Type:
Application
Filed:
November 22, 2006
Publication date:
May 31, 2007
Applicant:
Bayer CropScience GmbH
Inventors:
Gerhard Frisch, Ulrike Ebersold, Janine Rude
Abstract: The invention concerns a novel nucleic acid fragment of the genome of rice pathogenic fungus Magnaporthe grisea comprising a gene coding for a protein (hereafter referred to as gene 763) whereof the presence and integrity are indispensable for pathogenesis of said fungus with respect to rice and barley. The invention also concerns the promoter of said gene, the gene coding for protein 763, protein 763 and uses thereof for identifying potential biological targets for novel fungicide molecules and for isolating genes coding for proteins controlling biochemical functions essential to the pathogenesis of the fungus Magnaporthe grisea with respect to rice and barley. The invention further concerns compounds inhibiting pathogenesis of fungi related to the expression of gene 763.
Abstract: The invention relates to a method of finding compounds which increase the tolerance of plants to abiotic stress factors acting on this plant, such as, for example, temperature (such as chill, frost or heat), water (such as dryness, drought or anoxia), or the chemical load (such as lack of or excess of mineral salts, heavy metals, gaseous noxious substances) by increasing the expression of plant-endogenous proteins, and to the use of these compounds for increasing the tolerance in plants to abiotic stress factors.
Type:
Application
Filed:
November 27, 2006
Publication date:
May 31, 2007
Applicant:
Bayer CropScience GmbH
Inventors:
Arno Schulz, Klaus Bartsch, Hansjorg Krahmer, Martin Hills, Erwin Hacker, Chris Rosinger
Abstract: The present invention is directed to polyols prepared in the presence of double metal cyanide catalysts (“DMC”) which are prepared by combining i) at least one metal salt; ii) at least one metal cyanide salt; iii) at least one organic complexing ligand; iv) at least one alkali metal salt; and, optionally, v) at least one functionalized polymer under conditions sufficient to form a catalyst; and adding a sufficient amount of the at least one alkali metal salt to the catalyst so formed in an amount such that the catalyst includes the at least one alkali metal salt in an amount of from about 0.4 to about 6 wt. % based on the total weight of the catalyst. The polyols produced by the process of the present invention have reduced levels of high molecular weight tail.
Abstract: The present invention relates to an improved isocyanate reactive mixture containing at least one DMC-catalyzed polyol and about 0.25 to about 15 wt. %, based on the total weight of the isocyanate-reactive mixture, of at least one ethylene oxide (EO) containing water compatibilizer. The isocyanate reactive mixtures of the present invention may find use in the preparation of polyurethane foams, coatings, elastomers, sealants, adhesives and the like.
Type:
Grant
Filed:
October 10, 2003
Date of Patent:
May 29, 2007
Assignee:
Bayer MaterialScience LLC
Inventors:
David A. Radovich, Richard G. Skorpenske, Gary W. Munko
Abstract: A thermoplastic molding composition containing talc is disclosed. The composition wherein talc has a median particle size of less than 1000 nm further contains a polycarbonate and/or polyester-carbonate, and a graft polymer having as graft base a rubber having a glass transition temperature of below about 10° C. is suitable for preparing molded articles having improved mechanical properties, such as weld line strength, elongation at break and toughness at low temperatures.
Type:
Grant
Filed:
June 5, 2002
Date of Patent:
May 29, 2007
Assignee:
Bayer Aktiengesellschaft
Inventors:
Andreas Seidel, Marc Vathauer, Thomas Eckel, Holger Warth, Dieter Wittmann
Abstract: The present invention relates to a data processing system and method for seamlessly integrating laboratory information management system (LIMS) functionalities into an enterprise resource planning (ERP) system. The invention enables to keep the additional complexity that is required for the provision of LIMS functionalities at a minimum as all laboratory instrumentation setup information is centrally stored in a server computer but not in the ERP system.
Type:
Grant
Filed:
October 7, 2004
Date of Patent:
May 29, 2007
Assignee:
Bayer Business Services GmbH
Inventors:
Matthias Dräger, Rainer Schmitz, Gerhard Maldener, Dirk Spingat
Abstract: The invention relates to compounds of the formulae
Type:
Application
Filed:
December 15, 2006
Publication date:
May 24, 2007
Applicant:
Bayer Aktiengesellschaft
Inventors:
Jurgen Stoltefuss, Siegfried Goldmann, Thomas Kramer, Karl-Heinz Schlemmer, Ulrich Niewohner, Maria Niewohner, Arnold Paessens, Erwin Graef, Stefan Lottmann, Karl Deres, Olaf Weber, Jorn Stolting